Details for 2016791420

Up to date per 01.05.2026

Actions

Title / Product Name

ZUR KREBSBEHANDLUNG NÜTZLICHE DIHYDROIMIDAZOPYRAZINONDERIVATE

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016791420

EP Publication Number

3374359

E-Number

1222574

Language

PCT Number

EP16076932

Publication Date

19.09.2018 A

08.01.2020 B1

Registration Date

08.01.2020

AT Publication Date

15.02.2020

Application Date

08.11.2016

Registration Number

Priorities

09.11.2015

201562252726 P

29.09.2016

201662401351 P

IPC

C07D 487/04 20060101AFI20170601BHEP

Maximum Duration of Protection

08.11.2036

Owner

AstraZeneca AB 151 85 SödertäljeSE

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

WARD, Richard, AndrewAstraZeneca Darwin Building Cambridge Science Park Milton Road Cambridge CB4 0WGGB

JONES, Clifford, Davidc/o AstraZeneca Intellectual Property AstraZeneca Alderley Park Macclesfield Cheshire SK10 4TGGB

SWALLOW, StevenAstraZeneca Charter Way Macclesfield Cheshire SK10 2NAGB

GRAHAM, Mark, AndrewAstraZeneca Charter Way Macclesfield Cheshire SK10 2NAGB

DOBSON, Andrew, HornbyAstraZeneca Charter Way Macclesfield Cheshire SK10 2NAGB

MCCABE, James, FrancisAstraZeneca Charter Way Macclesfield Cheshire SK10 2NAGB